EPO Patents = 2

Forward Citations = 0

Loading Chart...

11 inventors (with patents filed for the assignee):

Hongping Yu (5 out of 18 patents)

Zhui Chen (5 out of 15 patents)

Yaochang Xu (5 out of 16 patents)

4. Shuqun Yang (3 out of 4 patents)

5. Fei Yang (3 out of 3 patents)

6. Mingming Zhang (2 out of 17 patents)

7. Baowei Zhao (2 out of 12 patents)

8. Haibing Deng (1 out of 10 patents)

9. Haiyan Ying (1 out of 5 patents)

10. Yongxian Zhang (1 out of 3 patents)

11. Tao Feng (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12753164 - Pyrimidine-4,6-diamine derivative, a preparation method therefor, and a pharmaceutical application thereof (2026-10-06),

2. 12703703 - FGFR and mutation inhibitor thereof, preparation method therefor and use thereof (2026-08-11),

3. 12692264 - Pyrimidine or pyridine derivative, preparation method therefor, and application thereof in pharmacy (2026-07-28),

4. 12649727 - EFGR inhibitor, preparation method therefor and application thereof (2026-06-09),

5. 12552811 - Immunosuppressant, and preparation method therefor and use thereof (2026-02-17),

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#455 in Shanghai

#5,228 in China

Shanghai, China

Abbisko Therapeutics Co., Ltd.

Forward Citations = 0

11 inventors:

Hongping Yu (5 out of 18 patents)

Zhui Chen (5 out of 15 patents)

Yaochang Xu (5 out of 16 patents)

4. Shuqun Yang (3 out of 4 patents)

5. Fei Yang (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Abbisko Therapeutics Co., Ltd.. Retrieved from https://idiyas.com/company/abbisko-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]